NCT04625075View on ClinicalTrials.gov

Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19)

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

June 10, 2020

Primary Completion Date

June 10, 2021

Study Completion Date

February 3, 2022

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Cardiac MRI

Cardiac MRI with gadolinium and manganese contrast

DIAGNOSTIC_TEST

Cardiac CT

Cardiac CT to assess coronaries

DIAGNOSTIC_TEST

Electrocardiogram (ECG)

ECG to assess rhythm

DIAGNOSTIC_TEST

Blood samples

renal function liver function full blood count, hematocrit glucose

Trial Locations (1)

EH146SB

University of Edinburgh, Edinburgh

All Listed Sponsors
lead

University of Edinburgh

OTHER

NCT04625075 - Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19) | Biotech Hunter | Biotech Hunter